vs
Side-by-side financial comparison of MMTec, Inc. (MTC) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.
PAVmed Inc. is the larger business by last-quarter revenue ($996.0K vs $807.5K, roughly 1.2× MMTec, Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -5749.7%, a 12215.4% gap on every dollar of revenue.
MMTec, Inc. is a global fintech enterprise that develops and delivers integrated trading technology solutions, including high-performance trading platforms, real-time market data services, and risk management systems. Its core clients cover brokerage firms, asset management institutions, and professional traders across North America and the Asia-Pacific region, helping financial market participants boost trading efficiency and operational security.
PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.
MTC vs PAVM — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $807.5K | $996.0K |
| Net Profit | $-46.4M | $64.4M |
| Gross Margin | 83.5% | -38.7% |
| Operating Margin | -189.7% | -1162.4% |
| Net Margin | -5749.7% | 6465.8% |
| Revenue YoY | — | 25.9% |
| Net Profit YoY | — | 464.4% |
| EPS (diluted) | $-1.84 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $807.5K | — | ||
| Q3 24 | — | $996.0K | ||
| Q2 24 | — | $979.0K | ||
| Q1 24 | — | $1.0M | ||
| Q4 23 | — | $1.0M | ||
| Q3 23 | — | $791.0K | ||
| Q2 23 | — | $166.0K | ||
| Q1 23 | — | $446.0K |
| Q2 25 | $-46.4M | — | ||
| Q3 24 | — | $64.4M | ||
| Q2 24 | — | $-10.8M | ||
| Q1 24 | — | $-15.2M | ||
| Q4 23 | — | $-14.0M | ||
| Q3 23 | — | $-17.7M | ||
| Q2 23 | — | $-14.5M | ||
| Q1 23 | — | $-17.9M |
| Q2 25 | 83.5% | — | ||
| Q3 24 | — | -38.7% | ||
| Q2 24 | — | -70.2% | ||
| Q1 24 | — | -72.7% | ||
| Q4 23 | — | -53.5% | ||
| Q3 23 | — | -124.9% | ||
| Q2 23 | — | -915.1% | ||
| Q1 23 | — | -201.8% |
| Q2 25 | -189.7% | — | ||
| Q3 24 | — | -1162.4% | ||
| Q2 24 | — | -1397.8% | ||
| Q1 24 | — | -1389.7% | ||
| Q4 23 | — | -1561.7% | ||
| Q3 23 | — | -1963.1% | ||
| Q2 23 | — | -9930.1% | ||
| Q1 23 | — | -4574.2% |
| Q2 25 | -5749.7% | — | ||
| Q3 24 | — | 6465.8% | ||
| Q2 24 | — | -1105.9% | ||
| Q1 24 | — | -1506.1% | ||
| Q4 23 | — | -1338.0% | ||
| Q3 23 | — | -2234.0% | ||
| Q2 23 | — | -8757.2% | ||
| Q1 23 | — | -4020.4% |
| Q2 25 | $-1.84 | — | ||
| Q3 24 | — | $1.44 | ||
| Q2 24 | — | $-1.19 | ||
| Q1 24 | — | $-2.62 | ||
| Q4 23 | — | $-1.90 | ||
| Q3 23 | — | $-2.38 | ||
| Q2 23 | — | $-2.10 | ||
| Q1 23 | — | $-2.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.2M | $765.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-19.8M | $-4.9M |
| Total Assets | $20.3M | $30.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $10.2M | — | ||
| Q3 24 | — | $765.0K | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | — | $25.5M | ||
| Q4 23 | — | $19.6M | ||
| Q3 23 | — | $26.4M | ||
| Q2 23 | — | $37.2M | ||
| Q1 23 | — | $49.3M |
| Q2 25 | $-19.8M | — | ||
| Q3 24 | — | $-4.9M | ||
| Q2 24 | — | $-73.9M | ||
| Q1 24 | — | $-68.8M | ||
| Q4 23 | — | $-53.8M | ||
| Q3 23 | — | $-43.3M | ||
| Q2 23 | — | $-31.5M | ||
| Q1 23 | — | $-22.1M |
| Q2 25 | $20.3M | — | ||
| Q3 24 | — | $30.6M | ||
| Q2 24 | — | $39.4M | ||
| Q1 24 | — | $37.3M | ||
| Q4 23 | — | $33.1M | ||
| Q3 23 | — | $42.0M | ||
| Q2 23 | — | $53.7M | ||
| Q1 23 | — | $65.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-8.9M |
| Free Cash FlowOCF − Capex | — | $-8.9M |
| FCF MarginFCF / Revenue | — | -892.5% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | — | -0.14× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-45.8M |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $-1.7M | — | ||
| Q3 24 | — | $-8.9M | ||
| Q2 24 | — | $-11.7M | ||
| Q1 24 | — | $-13.1M | ||
| Q4 23 | — | $-11.9M | ||
| Q3 23 | — | $-11.1M | ||
| Q2 23 | — | $-12.7M | ||
| Q1 23 | — | $-16.4M |
| Q2 25 | — | — | ||
| Q3 24 | — | $-8.9M | ||
| Q2 24 | — | $-11.7M | ||
| Q1 24 | — | $-13.2M | ||
| Q4 23 | — | $-12.1M | ||
| Q3 23 | — | $-11.1M | ||
| Q2 23 | — | $-12.7M | ||
| Q1 23 | — | $-16.4M |
| Q2 25 | — | — | ||
| Q3 24 | — | -892.5% | ||
| Q2 24 | — | -1190.9% | ||
| Q1 24 | — | -1302.1% | ||
| Q4 23 | — | -1149.4% | ||
| Q3 23 | — | -1404.2% | ||
| Q2 23 | — | -7666.3% | ||
| Q1 23 | — | -3674.4% |
| Q2 25 | — | — | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 4.2% | ||
| Q4 23 | — | 17.4% | ||
| Q3 23 | — | 2.3% | ||
| Q2 23 | — | 9.0% | ||
| Q1 23 | — | 5.8% |
| Q2 25 | — | — | ||
| Q3 24 | — | -0.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
